Detection of SARS-CoV-2 IgG antibodies and inflammatory cytokines in saliva-a pilot study
- PMID: 36846089
- PMCID: PMC9937664
- DOI: 10.1016/j.jobcr.2023.02.008
Detection of SARS-CoV-2 IgG antibodies and inflammatory cytokines in saliva-a pilot study
Erratum in
-
Erratum regarding missing declaration of competing interest statements in previously published articles.J Oral Biol Craniofac Res. 2024 Jul-Aug;14(4):351-352. doi: 10.1016/j.jobcr.2024.05.008. Epub 2024 May 22. J Oral Biol Craniofac Res. 2024. PMID: 38826836 Free PMC article.
-
Erratum regarding missing Ethical statements in previously published articles.J Oral Biol Craniofac Res. 2024 Sep-Oct;14(5):668. doi: 10.1016/j.jobcr.2024.09.006. Epub 2024 Sep 17. J Oral Biol Craniofac Res. 2024. PMID: 39318850 Free PMC article.
Abstract
Objective: The pandemic caused by SARS-CoV-2 virus continues to have a profound effect worldwide. However, COVID-19 induced oral facial manifestations have not been fully described. We conducted a prospective study to demonstrate feasibility of anti-SARS-CoV-2 IgG and inflammatory cytokine detection in saliva. Our primary objective was to determine whether COVID-19 PCR positive patients with xerostomia or loss of taste had altered serum or saliva cytokine levels compared to COVID-19 PCR positive patients without those oral symptoms. Our secondary objective was to determine the correlation between serum and saliva COVID-19 antibody levels.
Materials and methods: For cytokine analysis, saliva and serum were obtained from 17 participants with PCR-confirmed COVID-19 infection at three sequential time points, yielding 48 saliva samples and 19 paired saliva-serum samples from 14 of the 17 patients. For COVID-19 antibody analyses, an additional 27 paired saliva-serum samples from 22 patients were purchased.
Results: The saliva antibody assay had 88.64% sensitivity [95% Confidence Interval (CI) 75.44%, 96.21%] to detect SARS-CoV-2 IgG antibodies compared to serum antibody. Among the inflammatory cytokines assessed - IL-6, TNF-α, IFN-γ, IL-10, IL-12p70, IL-1β, IL-8, IL-13, IL-2, IL-5, IL-7 and IL-17A, xerostomia correlated with lower levels of saliva IL-2 and TNF-α, and elevated levels of serum IL-12p70 and IL-10 (p < 0.05). Loss of taste was observed in patients with elevated serum IL-8 (p < 0.05).
Conclusions: Further studies are needed to construct a robust saliva-based COVID-19 assay to assess antibody and inflammatory cytokine response, which has potential utility as a non-invasive monitoring modality during COVID-19 convalescence.
Keywords: COVID-19; Coronavirus; Inflammation; Oral-systemic disease(s); Saliva; Xerostomia.
© 2023 The Authors.
References
-
- Amorim Dos Santos J., Normando A.G.C., Carvalho da Silva R.L., et al. Oral manifestations in patients with COVID-19: a living systematic review. J Dent Res. 2021;100(2):141–154. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
